Skip to main content
. 2022 May 13;10:837428. doi: 10.3389/fcell.2022.837428

TABLE 2.

Correlation analysis between STAT1 and biomarkers of immune cells in HCC (GEPIA).

Immune cell Biomarker R-value p-value
B-cell CD19 0.38 a 7.3e-14***, a
CD79A 0.47 a 6.8e-22***, a
CD8+ T-cell CD8A 0.54 a 4.4e-29***, a
CD8B 0.45 a 4.7e-20***, a
CD4+ T-cell CD4 0.45 a 5.3e-20***, a
M1 macrophage NOS2 0.16 a 0.0015**, a
IRF5 0.31 a 7.5e-10***, a
PTGS2 0.4 a 1e-15***, a
M2 macrophage CD163 0.34 a 1.4e-11***, a
VSIG4 0.39 a 8.5e-15***, a
MS4A4A 0.47 a 2.1e-21***, a
CD68 0.43 a 9.5e-18***, a
Neutrophil CEACAM8 0.047 0.37
ITGAM 0.42 a 6.7e-17***, a
CCR7 0.47 a 2e-21***, a
Dendritic cell HLA-DPB1 0.56 a 1.9e-31***
HLA-DQB1 0.31 a 1.3e-09***, a
HLA-DRA 0.58 a 3.2e-34***, a
HLA-DPA1 0.57 a 2.1e-33***, a
CD1C 0.42 a 1.6e-17***, a
NRP1 0.37 a 2.3e-13***, a
ITGAX 0.51 a 2.8e-26***, a
a

These results are statistically significant; *p-value <0.05; **p-value <0.01; ***p-value <0.001.